Sarilumab (interleukin-6 receptor monoclonal antibody) for the treatment of pemphigus vulgaris. Andrew K, Dhariwal SK, Szczecinska W. Clin Exp Dermatol 2023;48:1055-1056.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Andrew K, Dhariwal SK, Szczecinska W. Sarilumab (interleukin-6 receptor monoclonal antibody) for the treatment of pemphigus vulgaris. Clin Exp Dermatol 2023;48:1055-1056.
PMID: 37146158